Replies to post #208 on Immune Pharmaceuticals Inc (fka IMNPQ)

[ARBITRARY & CAPRICIOUS]

That is not the partner deal for amiket

[xr_biotech_consult]

In late December 2014, Immune initiated a comprehensive process targeting the 20 most likely development and commercial partners with the objective of commercializing AmiKet™. Several companies are in advanced due diligence and term sheet discussions. The company continues to anticipate an agreement to develop and commercialize AmiKet™ during 2015.